market rumours suggest Allergen (US$17 billion), or Biogen (US$12.5 billion) as possible targets.fairly big bites for us to digest but I suppose we could give it a go!
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint